Otsuka, a global healthcare company, completed the acquisition of Proteus Digital Health, a digital therapeutics startup. Financial terms were not disclosed. "The purchase of Proteus assets and intellectual property will serve as a catalyst for implementing the next phase of our digital medicine program. More than ever before, Otsuka remains committed to building a best-in-class digital healthcare business that includes both digital medicine and digital therapeutics," Kabir Nath, Otsuka North America Pharmaceutical Business President and CEO.